Often (it affects 2% of people over 65), Parkinson’s disease is primarily diagnosed by clinical examination supplemented by functional imaging. In particular, the doctor will try to determine if the patient has at least two of the three main symptoms of this neurodegenerative pathology: slowness of movement, stiffness and tremor at rest. But if these symptoms are present, it means that more than half of the dopaminergic neurons (which were destroyed by the disease) have already disappeared.
This is why many teams are mobilizing around the world to find out which biomarker can provide key information about disease progression. ” It is the scripture we all aspire to », recognizes Marc Verin, professor of neurology at Rennes University Hospital. The outlook appears to be getting closer with a study released this Thursday Lancet Neurology, confirming the interest of the alpha-synuclein trace…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.